老年髋部骨折患者血清戊糖素、RAGE、sRAGE水平与骨密度的关系

doi:10.3877/cma.j.issn.2096-0263.2021.02.007

中华老年骨科与康复电子杂志 ›› 2021, Vol. 07 ›› Issue (02) : 105 -110. doi: 10.3877/cma.j.issn.2096-0263.2021.02.007

所属专题：文献；

髋部骨折

老年髋部骨折患者血清戊糖素、RAGE、sRAGE水平与骨密度的关系

高俊¹, 蔡林秀², 张曦¹, 王娟³, 李春梅³, 胡继红⁴^,^†(

)

^1. 213003　常州市中医医院骨科
^2. 210046　南京中医药大学研究生院
^3. 213003　常州市中医医院骨科检验科
^4. 213003　常州市第二人民医院I期临床实验中心

收稿日期:2020-08-06 出版日期:2021-04-05
通信作者: 胡继红
基金资助:
常州市卫生计生委青年人才科技项目(QN201721)

Correlation between the serum levels of pentosidine, RAGE, sRAGE and bone mineral density in elderly patients with hip fracture

Jun Gao¹, Linxiu Cai², Xi Zhang¹, Juan Wang³, Chunmei Li³, Jihong Hu⁴^,^†()

^1. Department of Orthopaedics, Changzhou Chinese Traditional Medicine Hospital Affiliated to Chinese Traditional Medical University of Nanjing, Changzhou 213003, China
^2. School of graduate, Nanjing University of Traditional Chinese Medicine, Nanjing, 210046, China
^3. Department of Laboratory Medicine, Changzhou, Chinese Traditional Medicine Hospital Affiliated to Chinese Traditional Medical University of Nanjing, Changzhou 213003, China
^4. Department of Phase I Clinical Center, Changzhou NO.2 Hospital, Changzhou 213003, China

Received:2020-08-06 Published:2021-04-05
Corresponding author: Jihong Hu

全文 ( ) 下载PDF ( ) 导出引用

引用本文：

高俊, 蔡林秀, 张曦, 王娟, 李春梅, 胡继红. 老年髋部骨折患者血清戊糖素、RAGE、sRAGE水平与骨密度的关系[J/OL]. 中华老年骨科与康复电子杂志, 2021, 07(02): 105-110.

Jun Gao, Linxiu Cai, Xi Zhang, Juan Wang, Chunmei Li, Jihong Hu. Correlation between the serum levels of pentosidine, RAGE, sRAGE and bone mineral density in elderly patients with hip fracture[J/OL]. Chinese Journal of Geriatric Orthopaedics and Rehabilitation(Electronic Edition), 2021, 07(02): 105-110.

目的

了解老年髋部骨折患者血清戊糖素、晚期糖基化终末产物受体（RAGE）和sRAGE水平的状况，探讨这些指标与骨密度（BMD）正常、骨量减少和骨质疏松之间的关系。

方法

回顾性分析2018年01月至2019年06月，常州市中医医院治疗的老年髋部骨折66例患者，其中女性49例，男性17例，平均年龄（68±9）岁。患者常规检测L_2~4节段BMD的T值，依据BMD的T值不同将病例分为三组：骨密度正常组、骨量减少组和骨质疏松组。酶联免疫吸附测定血清戊糖素、RAGE、sRAGE水平，并检测生化指标血碱性磷酸酶（ALP）等的水平。分析血清戊糖素、RAGE、sRAGE水平与腰椎BMD的相关性。

结果

骨量减少组和骨质疏松组血清戊糖素、RAGE水平显著高于骨密度正常组相比（血清戊糖素三组间方差分析：F=10.779，P=0.000，骨量减少组与骨质疏松组血清戊糖素LSD两两比较P=0.116，骨量减少组与骨密度正常组血清戊糖素LSD两两比较P=0.006，骨质疏松组与骨密度正常组血清戊糖素LSD两两比较P=0.000；RAGE三组间方差分析F=11.331，P=0.000，骨量减少组与骨质疏松组RAGE LSD两两比较P=0.057，骨量减少组与骨密度正常组RAGE LSD两两比较P=0.010，骨质疏松组与骨密度正常组RAGE LSD两两比较P=0.000），骨量减少组和骨质疏松组sRAGE水平显著低于骨密度正常组（sRAGE三组间方差分析F=14.211，P=0.000，骨量减少组与骨质疏松组sRAGE LSD两两比较P=0.046，骨量减少组与骨密度正常组sRAGE LSD两两比较P=0.003，骨质疏松组与骨密度正常组sRAGE LSD两两比较P=0.000）；血清戊糖素、RAGE水平与腰椎BMD呈负相关性（r=-0.575，P=0.000；r=-0.446，P=0.000），血清sRAGE水平与腰椎BMD呈正相关性（r=0.618，P=0.000）。

结论

血清戊糖素、RAGE及sRAGE水平与腰椎BMD之间有显著的相关性，可作为临床骨质疏松症诊断的参考参数，值得临床开展应用。

关键词: 老年人, 髋骨折, 骨密度, 晚期糖基化终末产物

Objective

This study aims to explore the correlation of serum levels of pentosidine, receptor for advanced glycation end-product (RAGE) and soluble receptor for advanced glycation end-product (sRAGE) in elderly patients with hip fractures with their bone mass density (BMD).

Methods

A retrospective analysis was conducted for 66 elderly patients with hip fractures hospitalized in our Department of Orthopedics between January 2018 and June 2019. Dual-energy X-ray absorptiometry was used to measure the BMDs of the 2nd-4th lumbar; enzyme-linked immunosorbent assay was adopted to determine the levels of serum pentosidine, RAGE and sRAGE, and automatic biochemical analyzer was utilized to analyze the serum levels of alkaline phosphatase (ALP), tartrate-resistant acid phosphatase 5b (TRACP5b), osteocalcin (OC), calcium (Ca), and substance P (P). Based on their BMDs, all patients were divided into a normal bone mass group, an osteopenia group, and an osteoporosis group.

Results

Compared with the normal bone mass group, the levels of serum pentosidine and RAGE in osteopenia group and osteoporosis group were significantly higher (Analysis of variance among the three groups of serum pentosidine F=10.779, P=0.000. There were significant differences between the two groups (P=0.116, P=0.006, P=0.000). Analysis of variance among the three groups of serum pentosidine (F=11.331, P=0.000). There were significant differences between the two groups (P=0.057, P=0.010, P=0.000). The levels of sRAGE in osteopenia group and osteoporosis group were significantly lower (Analysis of variance among the three groups of serum sRAGE (F=14.211, P=0.000). There were significant differences between the two groups (P=0.046, P=0.003, P=0.000). There was a significant negative correlation between serum pentosidine level and lumbar BMD (r=-0.575, P=0.000), a significant negative correlation between serum RAGE level and lumbar BMD (r=-0.446, P=0.000), and a significant positive correlation between serum sRAGE level and lumbar BMD (r=0.618, P=0.000).

Conclusion

There is a significant correlation between serum pentosidine, RAGE, sRAGE levels and lumbar BMD, which can be used as a reference parameter for the diagnosis of osteoporosis and is worthy of clinical application.

Key words: Aged, Hip fractures, Bone mineral density, AGEs

表1 骨密度正常组、骨量减少组和骨质疏松组老年髋部骨折患者纳入人群一般特征

组别	例数	性别（例，男/女）	年龄（岁，±s）	骨折时间（天，±s）	BMI（kg/m²，±s）	ALP（U/L，±s）	TRACP5b（ug/L，±s）
骨密度正常组	24	7/17	67.45±10.63	2.15±0.52	24.14±1.68	64.09±10.43	4.58±1.1
骨量减少组	20	4/16	68.45±8.79	2.09±0.54	24.83±2.15	64.9±9.7	4.98±1.06
骨质疏松组	22	6/16	67.13±5.97	2.19±0.57	26.1±2.38	65.35±9.02	5.52±1.2
F/χ²值		0.512	0.144	0.059	5.180	0.010	4.024
P值		0.767	0.871	0.803	0.012	0.912	0.024
组别	例数	OC（ug/L，±s）	Ca（mmol/L，±s）	P（mmol/L，±s）	BMD（T值，±s）
骨密度正常组	24	6.4±1.08	2.37±0.06	1.17±0.11	0.38±0.78
骨量减少组	20	5.8±1.45	2.33±0.06	1.18±0.11	-1.4±0.38
骨质疏松组	22	5.59±0.84	2.34±0.07	1.22±0.18	-3.48±0.87
F/χ²值		2.156	2.448	0.846	5.182
P值		0.110	0.086	0.443	0.011

表1 骨密度正常组、骨量减少组和骨质疏松组老年髋部骨折患者纳入人群一般特征

组别	例数	性别（例，男/女）	年龄（岁，±s）	骨折时间（天，±s）	BMI（kg/m²，±s）	ALP（U/L，±s）	TRACP5b（ug/L，±s）
骨密度正常组	24	7/17	67.45±10.63	2.15±0.52	24.14±1.68	64.09±10.43	4.58±1.1
骨量减少组	20	4/16	68.45±8.79	2.09±0.54	24.83±2.15	64.9±9.7	4.98±1.06
骨质疏松组	22	6/16	67.13±5.97	2.19±0.57	26.1±2.38	65.35±9.02	5.52±1.2
F/χ²值		0.512	0.144	0.059	5.180	0.010	4.024
P值		0.767	0.871	0.803	0.012	0.912	0.024
组别	例数	OC（ug/L，±s）	Ca（mmol/L，±s）	P（mmol/L，±s）	BMD（T值，±s）
骨密度正常组	24	6.4±1.08	2.37±0.06	1.17±0.11	0.38±0.78
骨量减少组	20	5.8±1.45	2.33±0.06	1.18±0.11	-1.4±0.38
骨质疏松组	22	5.59±0.84	2.34±0.07	1.22±0.18	-3.48±0.87
F/χ²值		2.156	2.448	0.846	5.182
P值		0.110	0.086	0.443	0.011

图1~3 各组老年髋部骨折患者戊糖素、RAGE及sRAGE的比较

图6 各组老年髋部骨折患者sRAGE与腰椎BMD相关分析

1	毛雷音，傅育红，徐颢庭.加速康复理念下高龄髋部骨折围手术期饮食方案的制定及应用研究[J/CD].中华老年骨科与康复电子杂志, 2020, 6(6): 357-363.
2	常晓，张保中，翁习生,等.高龄髋部骨折术后院内死亡的危险因素分析[J/CD].中华老年骨科与康复电子杂志, 2017, 3(1): 43-49.
3	梁伟，吴斗，赵恩哲,等.皮质厚度在骨质疏松性髋部骨折中的应用研究[J/CD].中华老年骨科与康复电子杂志, 2018, 4(3): 184-188.
4	Tanaka K, Yamagata K, Kubo S, et al. Glycolaldehyde-modified advanced glycation end-products inhibit differentiation of human monocytes into osteoclasts via upregulation of IL-10 [J]. Bone, 2019, 128: 115034.
5	Thomas CJ, Cleland TP, Sroga GE. Accumulation of carboxymethyllysine (CML) in human cortical bone [J]. Bone, 2018, 110: 128-133.
6	Choi DH, Lee SM, Lim SA, et al. Feasibility of serum pentosidine level as a potential risk factor for osteoporotic vertebral compression fracture [J]. Asian Spine J, 2018, 12(6): 992-997.
7	Tamaki J, Kouda K, Fujita Y, et al. Ratio of endogenous secretory receptor for advanced glycation end products to pentosidine predicts fractures in men [J]. J Clin Endocrinol Metab, 2018, 103(1): 85-94.
8	Shiraki M, Kashiwabara S, Imai T, et al. The association of urinary pentosidine levels with the prevalence of osteoporotic fractures in postmenopausal women [J]. J Bone Miner Metab, 2019, 37(6): 1067-1074.
9	Creecy A, Uppuganti S, Girard MR, et al. The age-related decrease in material properties of BALB/c mouse long bones involves alterations to the extracellular matrix [J]. Bone, 2020, 130: 115126.
10	Saito M, Fujii K, Mori Y, et al. Role of collagen enzymatic and glycation induced cross-links as a determinant of bone quality in spontaneously diabetic WBN/Kob rats [J]. Osteoporos Int, 2006, 17(10): 1514-1523.
11	Allen MR, Gineyts E, Leeming DJ, et al. Bisphosphonates alter trabecular bone collagen cross-linking and isomerization in beagle dog vertebra [J]. Osteoporos Int, 2008, 19(3): 329-337.
12	Plotkin L, Essex AL, Davis HM. RAGE signaling in skeletal biology [J]. Curr Osteoporos Rep, 2019, 17(1): 16-25.
13	Ohishi T, Fujita T, Suzuki D, et al. Changes of bone mineral density and serum pentosidine during a 27-month follow-up of monthly minodronate in osteoporotic patients [J]. Endocr Res, 2017, 42(3): 232-240.
14	Prasad K. AGE-RAGE stress play a role in aortic aneurysm: A comprehensive review and novel potential therapeutic target [J]. Rev Cardiovasc Med, 2019, 20(4): 201-208.
15	Ebert H, Lacruz ME, Kluttig A, et al. Advanced glycation end products and their ratio to soluble receptor are associated with limitations in physical functioning only in women: results from the CARLA cohort [J]. BMC Geriatr, 2019, 19(1): 299.
16	Thomas MC, Söderlund J, Lehto M, et al. Soluble receptor for AGE (RAGE) is a novel Independent predictor of all-cause and cardiovascular mortality in type 1 diabetes [J]. Diabetologia, 2011, 54(10): 2669-2677.
17	Selvin E, Halushka MK, Rawlings AM, et al. sRAGE and risk of diabetes, cardiovascular disease, and death [J]. Diabetes, 2013, 62(6): 2116-2121.
18	Galliera E, Marazzi MG, Gazzaruso C, et al. Evaluation of circulating sRAGE in osteoporosis according to BMI, adipokines and fracture risk: a pilot observational study [J]. Immun Ageing, 2017, 14: 13.

[1]	蚁淳, 袁冬生, 熊学军. 系统免疫炎症指数与骨密度降低和骨质疏松的关联[J/OL]. 中华关节外科杂志(电子版), 2024, 18(05): 609-617.
[2]	陈翠萍, 李佩君, 杜景榕, 谢青梅, 许一宁, 卓姝妤, 李晓芳. 互联网联合上门护理在老年全髋关节置换术后的应用效果[J/OL]. 中华关节外科杂志(电子版), 2024, 18(05): 676-681.
[3]	陈晓玲, 钟永洌, 刘巧梨, 李娜, 张志奇, 廖威明, 黄桂武. 超高龄髋膝关节术后谵妄及心血管并发症风险预测[J/OL]. 中华关节外科杂志(电子版), 2024, 18(05): 575-584.
[4]	曾敬, 吴冬冬, 邵明, 范震波, 王治国, 刘培谊, 兰海峰. 高龄髋部骨折患者不同手术时机的围手术期疗效评估[J/OL]. 中华关节外科杂志(电子版), 2024, 18(04): 445-449.
[5]	宋俊锋, 张珍珍. 单侧初发性腹股沟斜疝老年患者经腹腹膜前疝修补术中残余疝囊腹直肌下缘固定效果评估[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 670-674.
[6]	张晋伟, 董永红, 王家璇. 基于GBD2021 数据库对中国与全球老年人疝疾病负担和健康不平等的分析比较[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 708-716.
[7]	袁志静, 黄杰, 何国安, 方辉强. 罗哌卡因联合右美托咪定局部阻滞麻醉在老年腹腔镜下无张力疝修补术中的应用[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(05): 557-561.
[8]	邵世锋, 肖钦, 沈方龙, 张迅, 郝志鹏, 伍正彬, 谢晓娟, 王耀丽. 老年胸主动脉钝性伤的重症救治分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 762-767.
[9]	王贝贝, 崔振义, 王静, 王晗妍, 吕红芝, 李秀婷. 老年股骨粗隆间骨折患者术后贫血预测模型的构建与验证[J/OL]. 中华老年骨科与康复电子杂志, 2024, 10(06): 355-362.
[10]	张骞, 唐伟, 刘丽丽. 右美托咪定复合羟考酮对老年经皮椎间孔镜腰椎间盘切除术患者术后认知功能、镇痛效果的影响[J/OL]. 中华老年骨科与康复电子杂志, 2024, 10(04): 209-214.
[11]	鲁宁, 魏立友, 李亮, 张玉龙. 老年桡骨远端骨折小夹板治疗后早期腕关节功能恢复的相关因素分析[J/OL]. 中华老年骨科与康复电子杂志, 2024, 10(04): 222-228.
[12]	崔健, 夏青, 林云, 李光玲, 李心娜, 王位. 血小板与淋巴细胞比值、免疫球蛋白、心肌酶谱及心电图对中老年肝硬化患者病情及预后的影响[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(05): 400-406.
[13]	李秀玲, 连少锋, 荣刘涛, 李登峰, 饶蕴玉. 利巴韦林联合复方嗜酸乳杆菌治疗轮状病毒肠炎患儿的临床研究[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(04): 369-372.
[14]	张青菊, 许建林, 南永刚, 施常备, 牛锦云. ^99mTc-MDP SPECT/CT定量骨显像测定腰椎标准化摄取值的分析及应用[J/OL]. 中华临床医师杂志(电子版), 2024, 18(03): 238-244.
[15]	崔晓珊, 铁涛, 袁坤山, 孙钢, 张海军, 金鹏. 骨质疏松症及其椎体压缩骨折局部与全身一体化防治的动物实验研究[J/OL]. 中华介入放射学电子杂志, 2024, 12(04): 369-373.

阅读次数

全文

摘要

选择文件类型/文献管理软件名称

选择包含的内容

Correlation between the serum levels of pentosidine, RAGE, sRAGE and bone mineral density in elderly patients with hip fracture

模态框（Modal）标题

选择文件类型/文献管理软件名称

选择包含的内容

Correlation between the serum levels of pentosidine, RAGE, sRAGE and bone mineral density in elderly patients with hip fracture